Okay, let's tackle this question about the treatment of Acute Myositis Ossificans. First, I need to recall what Acute Myositis Ossificans is. From what I remember, it's a condition where there's abnormal bone formation in the soft tissues, usually after an injury. It's also known as heterotopic ossification. The treatment would probably involve managing the inflammation and preventing further ossification.

The core concept here is probably the pathophysiology and treatment strategies for heterotopic ossification. The key is understanding that acute phase management focuses on reducing inflammation and preventing the progression of bone formation. So the correct answer might involve non-steroidal anti-inflammatory drugs (NSAIDs) like indomethacin. They are commonly used in the acute phase to suppress the inflammatory response that leads to ossification.

Now, looking at possible options. Let's say the options are A. NSAIDs, B. Corticosteroids, C. Bisphosphonates, D. Surgery. The correct answer here would be A. NSAIDs. Because NSAIDs are first-line in the acute phase. Corticosteroids might be used in some inflammatory conditions, but not typically for myositis ossificans. Bisphosphonates are used for osteoporosis or Paget's disease, not for this condition. Surgery would be considered in chronic cases once the ossification is stable, not in the acute phase.

Wait, but I should double-check. Some sources might mention corticosteroids as an option. However, the standard treatment is NSAIDs. Also, bisphosphonates might inhibit bone resorption but not the formation in this context. Surgery is contraindicated in the acute phase because it can worsen the condition. So the wrong options can be ruled out based on their mechanisms.

Clinical pearl: Remember that NSAIDs are key in the acute phase, and surgery is only after the lesion is mature. Also, the use of bisphosphonates is not indicated here. So the high-yield fact is the role of NSAIDs in preventing heterotopic ossification.

**Core Concept**
Acute myositis ossificans involves heterotopic bone formation in soft tissues, typically following trauma. The acute phase (first 2 weeks) requires anti-inflammatory treatment to suppress ossification. Key mechanisms include inflammation-driven osteoblast recruitment and extracellular matrix calcification.

**Why the Correct Answer is Right**
Nonsteroidal anti-inflammatory drugs (NSAIDs) like indomethacin are first-line in the acute phase. They inhibit cyclooxygenase (COX) enzymes, reducing prostaglandin-mediated inflammation and cytokine release. This suppresses the early inflammatory cascade that drives heterotopic ossification. NSAIDs must be initiated within the first 2 weeks of injury for maximal efficacy.

**Why Each Wrong Option is Incorrect**
**Option B:** Corticosteroids lack evidence for preventing heterotopic ossification and may delay healing. **Option C:** Bisphosphonates inhibit bone resorption but not heterotopic bone formation. **Option D:** Surgery is reserved for chronic cases after ossification is mature (6–12 months), not during the acute inflammatory phase.

**Clinical Pearl / High-Yield Fact**
NSAIDs are *only effective in the acute phase* of myositis oss

✓ Correct Answer: D. Immobilization